Battery technology business Novonix (ASX: NVX) has entered a binding offtake agreement to supply its high-performance synthetic graphite material to the battery cell manufacturing partners of multinational automotive titan, Stellantis. Commencing in 2026, the six-year deal will see Novonix deliver a minimum of 86,250 tonnes of graphite and up to 115,000 tonnes of the material
Read More
Equinox Resources (ASX: EQN) rallied after announcing that reconnaissance assay results from the maiden exploration program at its Alturas antimony project in British Columbia, Canada had returned ultra-high grade naturally occurring antimony, with assays up to 69.98% antimony. Equinox Resources also announced an expansion of its Alturas project, with the Company pegging two additional claims
Read More
Quickstep Holdings (ASX:QHL) has had a busy day, announcing (1) the successful finalisation of key negotiations with its Tier 1 defence customers, incorporating terms that reflect mutually acceptable volumes and pricing adjustments and (2) a takeover offer from ASDAM Operations Pty Limited. Contracts update C-130 Program with Lockheed Martin: Quickstep Holdings secures volume and increased
Read More
Second Benchmark testing for the ECS-DOT chipset by Embedded A.I Systems Pte. Ltd (EMASS) is scheduled to commence on 7 November, 2024, with results expected within a week The tests will focus on two critical applications, Anomaly Detection and Keyword Spotting, using standardised workloads from the MLPerf Tiny AI suite The EMASS ECS-DOT’s chipset performance
Read More
Those calling for the RBA to cut its benchmark interest rate on Melbourne Cup have backed the wrong horse – all they got was a hoarse voice! The RBA statement accompanying the Bank’s 5 November 2024 rates decision clearly stated the obstacles to any near term rate cut – and reiterated its ‘highest priority’, which
Read More
Clinical stage immuno-oncology company Imugene Limited (ASX:IMU) provided a clinical trial update of its Phase 1 MAST (Metastatic Advanced Solid Tumours) trial evaluating the safety and efficacy of novel cancer-killing virus CF33-hNIS (VAXINIA). Patient hits major milestone in CF33 MAST VAXINIA study, with ‘complete response’ for over two years The Cohort review committee has cleared
Read More
Ordell Minerals (ASX:ORD) has reported ‘significant drill results’ from its recent shallow, wide-spaced Reverse Circulation (RC) drilling program at the Company’s Barimaia Gold Project, located near Mount Magnet in the WA-based Murchison region. These RC drilling activities, completed in September and October 2024, represented the second phase of Ordell Minerals’ larger, ongoing program to systematically
Read More
Diversified mining business Mineral Resources (ASX:MIN) has struck a deal with Gina Rinehart’s Hancock Prospecting for the sale of two of its oil and gas exploration permits in the Perth Basin of Western Australia. In addition, the duo has entered joint venture (JV) agreements over Mineral Resources’ remaining exploration ground in the Perth Basin and
Read More
Shares in mineral exploration business OD6 Metals (ASX: OD6) rocketed by 75 per cent on Wednesday after the group reported its proposed acquisition of one of Australia’s highest grade historical copper mines, known as the Gulf Creek project. Located near the town of Burra in New South Wales, Gulf Creek is a volcanogenic massive sulphide
Read More
Digital financial services business Zip Co (ASX: ZIP) saw its share price jump by 12 per cent on Tuesday after delivering a strong set of numbers for the first quarter of FY25. Notably, group cash operating earnings (EBITDA) of $31.7 million soared by 234 per cent from the same time last year as the company
Read More
